STEPHEN J HOFFMAN
CIK 1190418 · Chief Executive Officer · last filed 2025-10-24
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$7.7K
Companies
7
Total Filings
41
Lifetime Open-Market Net
$9.40M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| TLPH | Director | 8,859 | $0.87 | $7.7K | $0 | 2 | 2025-10-24 |
| TALPHERA, INC. (ACRX) Delisted | Director | 2,874,351 | $0.86 | $2.47M | $0 | 8 | 2023-12-13 |
| Dicerna Pharmaceuticals Inc (DRNA) Delisted | Director | 312,000 | $38.22 | $11.92M | $3.00M | 9 | 2021-12-29 |
| Whitehawk Therapeutics, Inc. (ARPO) Delisted | Chief Executive Officer | 1,967 | $33.00 | $64.9K | $64.1K | 3 | 2019-05-16 |
| GENOCEA BIOSCIENCES, INC. (GNCA) Delisted | Director | 1,992,415 | $0.00 | $1.2K | $8.79M | 4 | 2016-06-07 |
| ALLOS THERAPEUTICS INC (ALTH) Delisted | Director | 0 | — | — | -$2.45M | 12 | 2012-09-05 |
| Sirtris Pharmaceuticals, Inc. (SIRT) Delisted | Director | 1,376,190 | — | — | $0 | 1 | 2007-05-31 |
Recent Filings · Page 3 of 5
41 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2015-06-29 | Dicerna Pharmaceuticals Inc (DRNA) Delisted | Grant (A) | — | $0 | EDGAR |
| 2015-03-17 | GENOCEA BIOSCIENCES, INC. (GNCA) Delisted | Buy (P) | +700,000 | $5.78M | EDGAR |
| 2015-03-02 | GENOCEA BIOSCIENCES, INC. (GNCA) Delisted | Grant (A) | — | $0 | EDGAR |
| 2014-03-11 | TALPHERA, INC. (ACRX) Delisted | Other (J) | −1,300,000 | $0 | EDGAR |
| 2014-02-11 | GENOCEA BIOSCIENCES, INC. (GNCA) Delisted | Mixed | +1,292,415 | $3.01M | EDGAR |
| 2014-02-05 | Dicerna Pharmaceuticals Inc (DRNA) Delisted | Mixed | +1,734,751 | $3.00M | EDGAR |
| 2013-09-16 | TALPHERA, INC. (ACRX) Delisted | Buy (P) | — | $0 | EDGAR |
| 2012-09-05 | ALLOS THERAPEUTICS INC (ALTH) Delisted | U | −565,671 | -$1.03M | EDGAR |
| 2012-07-26 | TALPHERA, INC. (ACRX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2012-04-13 | ALLOS THERAPEUTICS INC (ALTH) Delisted | Grant (A) | +90,000 | $0 | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.